chr17-78991818-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 2P and 10B. PM2BP4_StrongBP6_ModerateBS1
The NM_001159773.2(CANT1):c.*1732T>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000567 in 227,674 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.00063 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00044 ( 1 hom. )
Consequence
CANT1
NM_001159773.2 3_prime_UTR
NM_001159773.2 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.774
Genes affected
CANT1 (HGNC:19721): (calcium activated nucleotidase 1) This protein encoded by this gene belongs to the apyrase family. It functions as a calcium-dependent nucleotidase with a preference for UDP. Mutations in this gene are associated with Desbuquois dysplasia with hand anomalies. Alternatively spliced transcript variants have been noted for this gene.[provided by RefSeq, Mar 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 17-78991818-A-G is Benign according to our data. Variant chr17-78991818-A-G is described in ClinVar as [Benign]. Clinvar id is 891913.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population eas. gnomad4 allele frequency = 0.00063 (96/152374) while in subpopulation EAS AF= 0.0139 (72/5188). AF 95% confidence interval is 0.0113. There are 0 homozygotes in gnomad4. There are 52 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CANT1 | NM_001159773.2 | c.*1732T>C | 3_prime_UTR_variant | 5/5 | ENST00000392446.10 | ||
CANT1 | NM_001159772.2 | c.*1732T>C | 3_prime_UTR_variant | 6/6 | |||
CANT1 | NM_138793.4 | c.*1732T>C | 3_prime_UTR_variant | 4/4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CANT1 | ENST00000392446.10 | c.*1732T>C | 3_prime_UTR_variant | 5/5 | 1 | NM_001159773.2 | P1 | ||
CANT1 | ENST00000302345.6 | c.*1732T>C | 3_prime_UTR_variant | 4/4 | 2 | P1 | |||
CANT1 | ENST00000620915.4 | c.*1732T>C | 3_prime_UTR_variant | 4/4 | 5 | P1 | |||
CANT1 | ENST00000592228.1 | c.*527T>C | 3_prime_UTR_variant, NMD_transcript_variant | 4/4 | 5 |
Frequencies
GnomAD3 genomes AF: 0.000624 AC: 95AN: 152256Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
95
AN:
152256
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.000438 AC: 33AN: 75300Hom.: 1 Cov.: 0 AF XY: 0.000432 AC XY: 15AN XY: 34722
GnomAD4 exome
AF:
AC:
33
AN:
75300
Hom.:
Cov.:
0
AF XY:
AC XY:
15
AN XY:
34722
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000630 AC: 96AN: 152374Hom.: 0 Cov.: 33 AF XY: 0.000698 AC XY: 52AN XY: 74526
GnomAD4 genome
AF:
AC:
96
AN:
152374
Hom.:
Cov.:
33
AF XY:
AC XY:
52
AN XY:
74526
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
46
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Desbuquois dysplasia 1 Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at